verified99%+ Verified Purity
local_shippingFast EU Delivery
Myotrope
Homechevron_rightAll Peptideschevron_rightSemaglutide
Semaglutide
verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-semaglutide-5mg

Official Product Data Sheet

Semaglutide (5mg)

Ultra High >99.5% Purity

Vial Contents
5 mg Semaglutide (lyophilized powder)
Includes
3 ml bacteriostatic water for reconstitution
Form
Lyophilized white powder for optimal stability
Purity
≥99%, third-party tested (COA available)
Sequence
Long-acting GLP-1 analog (proprietary structure)
Molecular Formula
C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Mass
4113.64 g/mol
CAS No.
910463-68-2
Solubility
Reconstitute with sterile/bacteriostatic water (3 ml for ~1.67 mg/mL)
Storage
Lyophilized frozen; reconstituted refrigerated at 2–8°C for up to 28 days

Authorized Resellers

Available through our trusted partners

123peptide.com
verifiedVerified

123peptide.com

Europe

local_shipping1-3 Business Days

Buy from Partneropen_in_new
Retatrutridekopen.com
verifiedVerified

Retatrutridekopen.com

Europe

local_shipping3-5 Business Days

Buy from Partneropen_in_new
View all authorized resellersshopping_cart

Scientific Background

Semaglutide has become the gold standard for many people serious about sustainable weight loss. With once-weekly dosing and clinical proof of 10–15% average body weight reduction (often 15–20%+ in strong responders), it's one of the most effective tools available for appetite control and metabolic reset.

Semaglutide is a long-acting GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1, powerfully reducing hunger, slowing gastric emptying, and improving insulin sensitivity for significant, sustained weight loss.

Start low with this 5mg vial, titrate smoothly, and watch the scale move week after week. Whether you're coming from diet struggles or want to accelerate your progress, Semaglutide delivers real, life-changing results.

Intended Research Use

  • Dramatic appetite and food craving reduction
  • Slowed gastric emptying for longer-lasting fullness
  • Improved insulin sensitivity and blood sugar control
  • Clinically proven 10–15% average weight loss
  • GLP-1 receptor binding and metabolic pathway research

menu_bookScientific Publications

article

N Engl J Med (2021)

Once-Weekly Semaglutide in Adults with Overweight or Obesity

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/33567185/

article

JAMA (2021)

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/33625476/

article

JAMA (2021)

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/33625476/

Clinical Evidence: In phase 3 clinical trials, semaglutide at maintenance doses led to 10–15% average body weight loss over 68 weeks, with many participants achieving 15–20%+ reduction when combined with lifestyle changes. It significantly reduced visceral fat, improved HbA1c, blood pressure, and lipid profiles.

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Myotrope

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

Clinical research suggests combining Semaglutide with complementary peptides can enhance weight management outcomes. These combinations target multiple metabolic pathways for amplified fat-burning and appetite control effects.

Cagrilintide

Cagrilintide

arrow_forward

myo-cagrilintide-5mg

Combines GLP-1 with amylin analog for enhanced satiety and superior weight loss synergy (CagriSema approach).

AOD-9604

AOD-9604

arrow_forward

myo-hgh-fragment-aod-9604-5mg

Pairs appetite control with targeted fat metabolism for localized contouring support.

Retatrutide

Retatrutide

arrow_forward

myo-retatrutide-10mg

Adds GIP/glucagon activation to semaglutide's GLP-1 for amplified fat-burning and energy effects.

schedule

Cycling Note: Continue for sustained weight loss; clinical trials support 68+ weeks of continuous use for optimal results.